KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Equity Income (2016)

Historic Equity Income for Charles River Laboratories International (CRL) over the last 5 years, with Q3 2016 value amounting to $442000.0.

  • Charles River Laboratories International's Equity Income fell 8635.8% to $442000.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $8.7 million, marking a year-over-year increase of 5804.99%. This contributed to the annual value of $3.8 million for FY2015, which is 5889.69% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Equity Income of $442000.0 as of Q3 2016, which was down 8635.8% from $5.0 million recorded in Q2 2016.
  • In the past 5 years, Charles River Laboratories International's Equity Income ranged from a high of $6.1 million in Q1 2014 and a low of -$907000.0 during Q2 2015
  • Over the past 5 years, Charles River Laboratories International's median Equity Income value was $1.1 million (recorded in 2013), while the average stood at $1.4 million.
  • Its Equity Income has fluctuated over the past 5 years, first skyrocketed by 688222.22% in 2014, then crashed by 14368.98% in 2015.
  • Over the past 5 years, Charles River Laboratories International's Equity Income (Quarter) stood at -$373000.0 in 2012, then soared by 386.33% to $1.1 million in 2013, then soared by 80.15% to $1.9 million in 2014, then tumbled by 88.62% to $219000.0 in 2015, then soared by 101.83% to $442000.0 in 2016.
  • Its last three reported values are $442000.0 in Q3 2016, $5.0 million for Q2 2016, and $3.1 million during Q1 2016.